Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2501 participants
OBSERVATIONAL
2008-12-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility
NCT02835469
Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility Treatment
NCT04814940
Assessment of the Effectiveness of Menopur in Intrauterine Insemination
NCT01354834
A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)
NCT01416987
Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.
NCT02458768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Controlled ovarian hyperstimulation cases for ART
Exclusion Criteria
* Pregnancy, lactation or contraindication to pregnancy
* Ovarian cysts not related to polycystic ovarian syndrome
* Abnormal uterine bleeding
* Tumors in uterus, ovaries and breasts
* Ovarian hyperstimulation syndrome
* Thromboembolism or history of it
* Infertile due to other reason than anovulation
* High FSH level indication primary ovarian failure
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ferring Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Development Support
Role: STUDY_DIRECTOR
Ferring Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Busan Maria hospital
Busan, Busan, South Korea
Daegu Maria
Daegu, Daegu, South Korea
Daejeon Maria
Daejeon, Daejeon, South Korea
Daejeon Seoul Women Hospital
Daejeon, Daejeon, South Korea
Ellemedi Women Clinic
Daejeon, Daejeon, South Korea
Miz Women's Hospital
Daejeon, Daejeon Metropolitan City, South Korea
Seoul´s Women´s Hospital
Bucheon-si, Gyeonggi Province, South Korea
Ilsan Maria Hospital
Ilsan, Gyeonggi Province, South Korea
Incheon Seoul women Hospital
Incheon, Incheon, South Korea
Premedi Women's Clinic
Kwangju, Kwangju Metropolitan City, South Korea
Gumi CHA University Medical Center
Gumi, Kyoungbuk Province, South Korea
Mama Papa & Baby Hospital
Ulsan, Kyoungnam Province, South Korea
Cheil General Hospital & Women's Healthcare Center
Seoul, Seoul, South Korea
Gangseo Mizmedi Hospital
Seoul, Seoul, South Korea
Hamchoon women clinic
Seoul, Seoul, South Korea
Maria Plus Hospital
Seoul, Seoul, South Korea
Samsung Medical Center
Seoul, Seoul, South Korea
Songnae Maria Hospital
Seoul, Seoul, South Korea
Maria Hospital
Seoul, ´Shinseoul-dong, Dongdaemun-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FE999906 CS10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.